Thrombolysis with recombinant human tissue-type plasminogen activator of massive pulmonary embolism;Thrombolyse met RT-PA voor de behandeling voor massale longembolie

Journal Belge de Radiologie

Volumn 79, Issue 5, 1996, Pages 208-210

  Van Hover, Ph ^a   Stockx, L ^a   Raat, H ^a   Vervloessem, I ^a   Vandenbosch, G ^a   Verhaeghe, R ^a   Baert, A L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

embolism, pulmonary; thrombolysis

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; COUMARIN DERIVATIVE; ETHINYLESTRADIOL; GESTODENE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; INTERVENTIONAL RADIOLOGY; LUNG ANGIOGRAPHY; LUNG EMBOLISM; PRIORITY JOURNAL;

ADULT; ANGIOGRAPHY, DIGITAL SUBTRACTION; FEMALE; HUMANS; PLASMINOGEN ACTIVATORS; PULMONARY EMBOLISM; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0029796220     PISSN: 00217646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Leclercq F., Messner-Pellenc P., Beigbeder J.Y., Albat B., Thevenet A., Grolleau-Raoux R.: Floating thrombus in the right atrium and severe pulmonary embolism. Arch Mal Cœur Vaiss, 1994, 87: 805-11.
2. Lefevre T., Testart F., Boulet E., Garance P., Thebaut B., Bellorini M., Funck F., Trouillet G.: Thrombolyse et embolie pulmonaire massive: des resultats parfois spectaculaires. Ann Cardiol Angeiol, 1992, 41: 481-4.
3. Goldhaber S. Z.: Contemporary pulmonary embolism thrombolysis. Chest, 1995, 107(suppl. 1): 45s-51s.
4. Goldhaber et al.: Recent advances in the diagnosis and lytic therapy of pulmonary embolism. Chest, 1991, Apr. 99(4 suppl.): 173s-179s.
5. Prewitt R. M., Hoy C., Kong A., Gu S. A., Greenberg D., Cook R., Chan S. M., Ducas J.: Thrombolytic therapy in canine pulmonary embolism. Comparitive effects of urokinase and recombinant tissue plasminogen activator. Am Rev Respir Dis, 1990, Feb. 141: 290-5.
6. Levine M., Hirsch J., Weitz J., Cruickshank M., Neemeh J., Turpie A. G., Gent M.: A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest, 1990, Dec. 98: 1473-9.
7. Bozzoli C., Renzi C., Pudu G. M., Muscari A., Puddu P.: Treatment of pulmonary embolism. Current status and future prospects. Clin Ter, 1993; 142: 497-505.
8. Cortellaro M., Cofrancesco E., Polli E. E.: Rt-PA in extracardiac thromboembolic vascular occlusion. Ann Ital Med Int, 1990, Jan.-Mar. 5: 61-9.
9. Lang M., Charbonnier B., Quilliet L., Pacouret G., Poitrineau O., Mannara R., Neel G., Desveaux B., Raynaud P., Brochier M. L.: Tissue plasminogen activator (Alteplase) in acute massive pulmonary embolism. A pilot study. Arch Mal Cœur Vaiss, 1989, Nov. 82: 1803-11.
10. Goldhaber S. Z.: Tissue plasminogen activator in acute pulmonary embolism. Chest, May 1989, 95 (5 suppl.): 282s-289s.
11. Goldhaber S. Z., Kessler C. M., Heit J. A., Elliot C. G., Friedenberg W. R., Heiselman D. E., WilsonD. B., Parker J. A., Bennet D., Feldstein M. L. et al.: Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol, 1992, Jul. 20: 24-30.
12. Abel H.: Thrombolysis: the logical approach for the treatment of vascular occlusions. Acta Cardiol, 1992, 47: 287-95.
13. Aschauer M., Pilger E., Szolar D. H., Flueckiger F., Hausegger K., Stark G., Groell R., Klein G. E., Schreyer H.: Extended infusion of rt-PA lysis of pulmonary emboli: influence of time after onset of symptoms on outcome. Cardiovasc Intervent Radiol, 1995, 18: 288-290.
14. Goldhaber S. Z., Kassler C. M., Heit J.,Markis J. E., Sharma G. V., Dawley D. L., Meyerovitz M. F., Vaughan D. E., Parker J. A., Come P. C., et al.: Tissue plasminogen activator and acute pulmonary embolism. J Cell Biochem, 1988, Dec. 38: 303-12.
15. Levine M., Weitz J., Turpie A. G., Andrew M., Cruickshank M., Hirsch J.: A new short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic disease. Chest, 1990, Apr. 97(4 suppl.): 168s-171s.
16. Diehl J. L., Meyer G., Igual J., Collignon M. A., Giselbrecht M., Even P., Sors H.: Effectiveness and safety of bolus administration of Alteplase in massive pulmonary embolism. Am J Cardiol, 1992, Dec. 1; 70: 1477-80.
17. Agnelli G., Parise P.: Bolus thrombolysis in venous thromboembolism. Chest, 1992, Apr. 101(4 suppl.): 172s-182s.
18. Sors H., Pacouret G., Azarian R., Meyer G., Charbonnier B., Simonneau G.: Hemodynamic effects of bolus vs 2-h infusion of Alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest, 1994, 103: 712-7.
19. Goldhaber S. Z., Agnelli G., Levine M. N.: Reduced dose bolus Alteplase vs conventional Alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. Chest, 1994, 103: 718-24.
20. Goldhaber S. Z., Feldstein M. L., Sors H.: Two trials of reduced bolus Alteplase in the treatment of pulmonary embolism. Chest, 1994, 103: 725-6.